West on Lung Cancer

• Oncology Is Not Immune From Online 'Confirmation Bias' Far too often, online discussions among oncologists cross the line into specious and even dangerous territory.
  Medscape Oncology, October 15, 2020
• 5 Reasons Why Medical Meetings Will Never Be the Same Dr Jack West argues that we shouldn't necessarily rush to return to the previous status quo of live, in-person medical meetings.
  Medscape Oncology, September 09, 2020
• Why Are Oncologists Deviating From Best Evidence in NSCLC? Bringing practices in line with standard of care requires understanding why they're diverging in the first place, says Dr Jack West.
  Medscape Oncology, August 18, 2020
• We Can't Afford to Be 'Cost-Agnostic' With Our Cancer Patients Dr Jack West on how one oncologist's personal experience propelled her to make patients' financial hardships a viable treatment consideration.
  Medscape Oncology, June 11, 2020
• ADAURA Trial: Breaking Through the Hype Drs Jack West and Lecia Sequist discuss the pros and cons of the ADAURA trial, and whether focusing on only disease-free survival is enough for patients with EGFR mutation-positive NSCLC.
  Medscape Oncology, June 05, 2020
• Has 'Patient Centeredness' Gone Too Far? Patient centeredness is not a reason to accede to misguided medical decisions, argues Jack West.
  Medscape Oncology, May 29, 2020
• Why Is the UK so Much Better at Molecular Profiling? Drs Jack West and Sanjay Popat discuss the strengths and limitations of their respective US and UK systems for identifying and treating lung cancer with actionable mutations.
  Medscape Oncology, May 08, 2020
• 5 Key Targeted Therapy Advances for Lung Cancer Drs West and Aggarwal share their thoughts on the past decade's targeted therapy innovations, and how they may keep going well into the 2020s.
  Medscape Oncology, March 26, 2020
• Italian Oncologist's Cautionary Advice on COVID-19 for US Centers Marina Garassino, MD, chief of the Medical Thoracic Oncology Unit at the Istituto Nazionale dei Tumori in Milan, Italy, talks about her experience during Italy's COVID-19 outbreak.
  Medscape Oncology, March 20, 2020
• Top 5 Advances in Lung Cancer Immunotherapy Over the Past Decade Lung cancer experts Jack West and Charu Aggarwal highlight the biggest immunotherapy trials in thoracic oncology from 2010 to 2019.
  Medscape Oncology, January 23, 2020
• Overcoming Territoriality in Palliative Cancer Care Dr Jack West says it is time to embrace a team approach when it comes to initiating discussions about end-of-life care with patients with advanced cancer.
  Medscape Oncology, January 21, 2020
• 'Open Notes': Too Much Transparency With Patients? A new film about a terminal cancer diagnosis, along with his own institution's move to an open notes system, get Dr Jack West to thinking about how we disclose bad news to our patients with cancer.
  Medscape Oncology, November 07, 2019
• Time to Rethink Treating Brain Metastases in NSCLC? Dr Jack West on how immunotherapy has opened up new potential for intracranial disease control.
  Medscape Oncology, August 15, 2019
• New Targets in Lung Cancer Shape Treatment Options Thoracic oncologist Jack West talks about research presented at ASCO 2019 on new targets in lung cancer that may now be ready to move out of the research setting and into the clinic.
  Medscape Oncology, July 16, 2019
• Notion of Academic and Community Oncology 'Tribes' Needs to End   'You know, we're on the same team.' Drs West, Garon, and Lewis discuss the growing challenges of patient care in this world of information excess, particularly for those practicing in the community.
  Medscape Oncology, June 14, 2019
• 'Mind-boggling' IO Data, Plus New Combos, Targets for NSCLC   Drs West, Aggarwal, and Patel discuss the 'mind-boggling,' 'humbling,' and 'amazing' advances in survival statistics and targeted therapies for NSCLC presented at ASCO 2019.
  Medscape Oncology, June 07, 2019
• ASCO: Ain't Nothing Like the Real Thing, Baby Jack West, a long-time advocate of viewing ASCO meeting presentations virtually, reverses course after a meeting in which the excitement of connecting in person was especially tangible.
  Medscape Oncology, June 06, 2019
• 'How Could We Fail so Miserably?' A new study using real-world data suggests that far too many patients with driver mutations are dying without receiving effective treatments.
  Medscape Oncology, May 16, 2019
• Should We Be Doing Molecular Testing at the Time of Acquired Resistance? A study of ALK-positive lung cancer raises questions about the role of repeat biopsies, as well as the relative value of tissue versus plasma molecular testing.
  Medscape Oncology, April 10, 2019
• Linking Community and Academic Oncologists: Creating a New Model Can oncologists continue to deliver cancer care without subspecialization? Jack West envisions a team-based model that capitalizes on oncologists' unique strengths.
  Medscape Oncology, March 08, 2019